Specialized modeling partner ePD offers model-informed drug development services through pharmacometrics and quantitative systems pharmacology, positioning it as a specialized partner for oncology and other therapeutic areas across the drug development spectrum.

Venture growth focus With a client base spanning venture-backed startups to large pharma across all stages, there are opportunities to tailor flexible engagement models and cross-sell additional modeling services.

Differentiated CRO value In a crowded market of CROs, ePD's emphasis on advanced modeling and dose-optimization decision support can deliver faster, more informed decisions, making it attractive for sponsors seeking deep scientific guidance.

Regional talent access Based in Buffalo with a lean team, ePD can scale by tapping local academic and biotech ecosystems to access specialized talent and accelerate project timelines.

Digital marketing lift The tech stack supports digital marketing and lead capture; opportunities exist to publish oncology dosing modeling case studies and optimize SEO to attract venture-backed and large-company prospects.